Chemical Compound

Upadacitinib

CAS Registry Number 1310726-60-3
Upadacitinib chemical structure
Primary Record

Upadacitinib

Note: Only for scientific research or as raw materials for production.

In stock
3,058 g
Purity
99.6 %
CAS
1310726-60-3

Compound Identifiers & Properties

CAS
1310726-60-3
PubChem CID
58557659
SMILES
CC[C@@H]1CN(C[C@@H]1C2=CN=C3N2C4=C(NC=C4)N=C3)C(=O)NCC(F)(F)F
Canonical SMILES
CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12

Names & Synonyms

  • Upadacitinib
  • Rinvoq
  • ABT-494
  • 1310726-60-3
  • upadacitinibum
  • Upadicitinib
  • Upadacitinib anhydrous
  • upadacitinib hydrate
  • Upadacitinib [USAN]
  • ABT-494 enantiomer
  • Upadacitinib (Standard)
  • RefChem:57163
  • 4RA0KN46E0
  • UNII-4RA0KN46E0
  • UPADACITINIB [MI]
  • Upadacitinib, ABT-494
  • Upadacitinib (USAN/INN)
  • UPADACITINIB [INN]
  • Upadacitinib [USAN:INN]
  • Upadacitinib (ABT-494)
  • C17H19F3N6O
  • UPADACITINIB [WHO-DD]
  • ABT 494
  • DTXSID901027919
  • GTPL9246
  • orb1299762
  • SCHEMBL9991056
  • CHEMBL3622821
  • L04AA44
  • MFCD30502663
  • WYQFJHHDOKWSHR-MNOVXSKESA-N
  • DTXCID401513480
  • GLXC-10425
  • UPADACITINIB [ORANGE BOOK]
  • AMY16528
  • BCP19011
  • EX-A1628
  • BDBM50503287
  • EBC-26865
  • HY-19569R
  • MFCD30738063
  • s8162
  • AKOS030567686
  • ACN-052823
  • CS-6150
  • DB15091
  • ABBV-599 COMPONENT UPADACITINIB
  • ABT494;ABT-494;ABT 494
  • NCGC00588874-01
  • AC-30326
  • AS-56379
  • DA-78788
  • FA166721
  • HY-19569
  • NS00133778
  • J3.590.729G
  • C72237
  • D10994
  • A857968
  • (3S,4R)-3-ethyl-4-(1,5,7,10-tetrazatricyclo[7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaen-12-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide
  • Q27074125
  • (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide
  • Z2831495606
  • B0084-475295
  • (3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide
  • (3S,4R)-3-ethyl-4-(3H-imidazo(1,2-a)pyrrolo(2,3-e)pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide
  • (3R)-N-(2,2,2-Trifluoroethyl)-3alpha-(3H-3,4,6,8a-tetraaza-as-indacene-8-yl)-4alpha-ethylpyrrolidine-1-carboxamide
  • (3S,4R)-3- Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide
  • (3S,4R)-3-ethyl-4-(1,5,7,10-tetraazatricyclo(7.3.0.0^(2,6))dodeca-2(6),3,7,9,11-pentaen-12-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide
  • (3S,4R)-3-ethyl-4-(3H-imidazo(1,2-a)pyrrolo(2,3-e)pyrazin-8-yl)-N-(2,2,2- trifluoroethyl)pyrrolidine-1-carboxamide
  • (3S,4R)-3-ethyl-4-{1,5,7,10-tetraazatricyclo[7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaen-12-yl}-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide
  • 1-Pyrrolidinecarboxamide, 3-ethyl-4-(3H-imidazo(1,2-a)pyrrolo(2,3-e)pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-, (3S,4R)-
  • 1-Pyrrolidinecarboxamide, 3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-, (3S,4R)-
  • 1310726-59-0
  • 1831899-72-9
  • ABT-494; rel-(-)-(3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide; (3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide
  • N-(2,2,2-Trifluoroethyl)-3beta-ethyl-4beta-(3H-4,6,8a-triazacyclopenta[e]indole-8-yl)pyrrolidine-1-carboxamide
  • rel-(-)-(3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide
  • rel-(3R,4S)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide